APGEApogee Therapeutics, Inc.

$135.08
Latest close: security removed from listing or deregisteredSep 8, 2026what changed →

What is the market doing?

What the tape says about APGE

Apogee Therapeutics, Inc. is +262% over the past year while the S&P 500 is +20%: 241 points ahead of the market.

+262%

1-year return · S&P 500 +20%

vs 200-day average
+55%

vs 200-day average · a clear uptrend

RSI (14)
77

RSI (14) · overbought, bought harder than it has been sold

Below its 52-week high
0.00%

Below its 52-week high

2024-08-12$28.79 – $135.08 · dashed line: 200-day average2026-09-02
Details
Last close2026-09-02
$135.08
1 monthS&P 500 −0.30%
+0.72%
1 yearS&P 500 +20%
+262%
vs 50-day average$123.87
+9.0%
52-week high
$135.08
52-week low
$36.02
Annualised volatility
68%
Insider buying, net, 6 monthsForms 3/4/5 to 2026-06-30
−$134M
Calendar-year price return
YearReturn
2026 (year to date)+79%
2025+67%
2024+62%
Average return by calendar month, 2023–2026
MonthYearsPositiveAverage
Jan31 of 3−0.67%
Feb32 of 3−4.4%
Mar33 of 3+43%
Apr31 of 3−6.9%
May30 of 3−5.6%
Jun32 of 3+22%
Jul32 of 3+4.3%
Aug43 of 4+2.0%
Sep43 of 4+4.2%
Oct31 of 3+3.9%
Nov32 of 3+9.2%
Dec33 of 3+16%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.